ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2734

B55β Regulates T Cell Survival through the Modulation of AKT during Cytokine Deprivation

José C. Crispin1, Sokratis A. Apostolidis2, Noe Rodriguez Rodriguez1, Tran Nguyen2 and George C. Tsokos3, 1Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Rheumatology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Apoptosis, cytokines and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose . The abundance of cytokines controls the length of immune responses through poorly defined mechanisms. B55β is a molecule that triggers apoptosis in activated T cells when cytokine levels decrease. T cells from a subset of patients with systemic lupus erythematosus (SLE) exhibit resistance to apoptosis that is associated to failure to express B55β. The aim of this study was to determine the molecular mechanisms through which B55β controls the survival of activated T cells.

Methods: Most experiments were performed in human primary T cells obtained from healthy donors. MCF7 cells were used in some experiments. T cells were activated with anti-CD3 and anti-CD28 (1 μg/mL). After day 3, fresh RPMI and IL-2 (100 U/mL) were replenished every 48 hours. Apoptosis was induced at day 10 by transferring the cells to fresh RPMI devoid of IL-2, in the presence of IL-2 blockade (anti-human IL-2). Apoptosis was quantified by flow cytometry (Annexin V/ propidium iodide staining). Forced expression and knockdown of B55β was induced by transducing activated T cells with lentiviruses encoding human B55β or B55β-specific shRNAs, respectively. Protein phosphorylation status was assessed by flow cytometry and Western blotting. Induction of pro-apoptotic genes was quantified by real time PCR.  

Results . Maximal expression of B55β (protein) was reached after 2 hours of IL-2 deprivation. This induction was associated to dephosphorylation of AKT S473 and T308 that occurred 4 hours after IL-2 withdrawal. IL-2 deprivation-induced AKT dephosphorylation was abrogated in T cells infected with lentivirus encoding B55β-specific shRNA. Accordingly, apoptosis was significantly reduced by B55β knockdown. Complementary experiments showed that forced expression of B55β caused apoptosis of activated T cells that was associated to dephosphorylation of AKT S473. Simultaneous forced expression of AKT annulled apoptosis induced by B55β indicating that B55β induces cell death through inactivation of AKT. To determine the effects of IL-2 deprivation on the PI3K-AKT-mTOR axis, we assessed the phosphorylation status of 18 members of the pathway using an intracellular signaling array. The results confirmed that AKT is dephosphorylated by IL-2 deprivation but that the pathway is not uniformly downregulated. mTORC1 and its substrates were mostly not affected whereas other AKT substrates, in particular the pro-apoptotic protein Bad and the transcription factors FoxO1 and 3a, were activated by dephosphorylation. Accordingly, induction of pro-apoptotic genes regulated by FoxO factors was observed. Further experiments confirmed that B55β overexpression activates the FoxO factors inducing the upregulation of pro-apoptotic genes, in particular Noxa, Puma and HRK.

Conclusion . B55β is a key regulator of AKT. Upon its induction by IL-2 deprivation, it causes AKT dephophorylation triggering programmed cell death through the induction and activation of the BH3-only pro-apoptotic proteins Bad, Noxa, Puma, and HRK. Our results demonstrate a novel mechanism of how AKT is regulated in activated T cells in response to cytokine abundance.


Disclosure:

J. C. Crispin,
None;

S. A. Apostolidis,
None;

N. Rodriguez Rodriguez,
None;

T. Nguyen,
None;

G. C. Tsokos,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b55%ce%b2-regulates-t-cell-survival-through-the-modulation-of-akt-during-cytokine-deprivation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology